Mazzarella and colleagues analyzed 1250 patients with early-stage HER2-positive breast cancer and found that obesity (BMI ≥ 30) was significantly associated with a worse OS and a higher incidence of distant metastases in the ER-negative subgroup. The gene discussed is ERBB2; the disease is obesity due to melanocortin 4 receptor deficiency.